Cargando…
Novobiocin, a Newly Found TRPV1 Inhibitor, Attenuates the Expression of TRPV1 in Rat Intestine and Intestinal Epithelial Cell Line IEC-6
Background and Purpose: Novobiocin (NOVO), an ABC transporter inhibitor, decreases intestinal wall permeability of capsaicin (CAP), an ABC transporter substrate. However, the mechanism of this effect is not consistent with the action of NOVO as an ABC transporter inhibitor. We previously found that...
Autores principales: | Liang, Qianying, Lv, Xueli, Cai, Qing, Cai, Yun, Zhao, Boxin, Li, Guofeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196238/ https://www.ncbi.nlm.nih.gov/pubmed/30374305 http://dx.doi.org/10.3389/fphar.2018.01171 |
Ejemplares similares
-
Role of Serosal TRPV4-Constituted SOCE Mechanism in Secretagogues-Stimulated Intestinal Epithelial Anion Secretion
por: Cui, Yinghui, et al.
Publicado: (2021) -
TRPV1: Turning up the heat on intestinal tumorigenesis
por: de Jong, Petrus R, et al.
Publicado: (2014) -
Metformin Attenuates Bone Cancer Pain by Reducing TRPV1 and ASIC3 Expression
por: Qian, He-Ya, et al.
Publicado: (2021) -
TRPV1-Mediated Microglial Autophagy Attenuates Alzheimer’s Disease-Associated Pathology and Cognitive Decline
por: Wang, Chenfei, et al.
Publicado: (2022) -
The TRPV4 Agonist GSK1016790A Regulates the Membrane Expression of TRPV4 Channels
por: Baratchi, Sara, et al.
Publicado: (2019)